Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Weilbaecher

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Oncology (Williston Park, N.Y.)|September 22, 2006
Aromatase inhibitors and bone lossEdith A Perez, Katherine Weilbaecher
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Skeletal complications of breast cancer therapiesAngela Hirbe, Elizabeth A Morgan, Ozge Uluçkan, et al.
Breast Cancer Research and Treatment|February 16, 2021
Long-term outcome of (neo)adjuvant zoledronic acid therapy in locally advanced breast cancerAndrew P Jallouk, Sriram Paravastu, Katherine Weilbaecher, et al.
Breast Cancer Research and Treatment|December 5, 2016
Differences in the mutational landscape of triple-negative breast cancer in African Americans and CaucasiansFoluso O Ademuyiwa, Yu Tao, Jingqin Luo, et al.
Clinical & Experimental Metastasis|November 12, 2005
MRI detection of early bone metastases in b16 mouse melanoma modelsKaren M Gauvain, Joel R Garbow, Sheng-Kwei Song, et al.
The American Journal of Pathology|April 6, 2010
A role for the epithelial microenvironment at tumor boundaries: evidence from Drosophila and human squamous cell carcinomasMarcos Vidal, Lorena Salavaggione, Lourdes Ylagan, et al.
Blood|August 25, 2005
HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibitionLing Gao, Hongju Deng, Haibo Zhao, et al.
BMJ Case Reports|November 29, 2024
Remission of longstanding metastatic paraganglioma in a patient after use of zoledronic acidJustin Schutte, Mahta Mardani, Katherine Weilbaecher, et al.
Breast Cancer Research and Treatment|July 21, 2019
Assessing the effectiveness of the National Comprehensive Cancer Network genetic testing guidelines in identifying African American breast cancer patients with deleterious genetic mutationsFoluso O Ademuyiwa, Patricia Salyer, Yinjiao Ma, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 25, 2018
Circulating Receptor Activator of Nuclear Factor-κB (RANK), RANK ligand (RANKL), and Mammographic Density in Premenopausal WomenAdetunji T Toriola, Catherine M Appleton, Xiaoyu Zong, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Oncology (Williston Park, N.Y.)|September 22, 2006
Aromatase inhibitors and bone lossEdith A Perez, Katherine Weilbaecher
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Skeletal complications of breast cancer therapiesAngela Hirbe, Elizabeth A Morgan, Ozge Uluçkan, et al.
Breast Cancer Research and Treatment|February 16, 2021
Long-term outcome of (neo)adjuvant zoledronic acid therapy in locally advanced breast cancerAndrew P Jallouk, Sriram Paravastu, Katherine Weilbaecher, et al.
Breast Cancer Research and Treatment|December 5, 2016
Differences in the mutational landscape of triple-negative breast cancer in African Americans and CaucasiansFoluso O Ademuyiwa, Yu Tao, Jingqin Luo, et al.
Clinical & Experimental Metastasis|November 12, 2005
MRI detection of early bone metastases in b16 mouse melanoma modelsKaren M Gauvain, Joel R Garbow, Sheng-Kwei Song, et al.
The American Journal of Pathology|April 6, 2010
A role for the epithelial microenvironment at tumor boundaries: evidence from Drosophila and human squamous cell carcinomasMarcos Vidal, Lorena Salavaggione, Lourdes Ylagan, et al.
Blood|August 25, 2005
HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibitionLing Gao, Hongju Deng, Haibo Zhao, et al.
BMJ Case Reports|November 29, 2024
Remission of longstanding metastatic paraganglioma in a patient after use of zoledronic acidJustin Schutte, Mahta Mardani, Katherine Weilbaecher, et al.
Breast Cancer Research and Treatment|July 21, 2019
Assessing the effectiveness of the National Comprehensive Cancer Network genetic testing guidelines in identifying African American breast cancer patients with deleterious genetic mutationsFoluso O Ademuyiwa, Patricia Salyer, Yinjiao Ma, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 25, 2018
Circulating Receptor Activator of Nuclear Factor-κB (RANK), RANK ligand (RANKL), and Mammographic Density in Premenopausal WomenAdetunji T Toriola, Catherine M Appleton, Xiaoyu Zong, et al.
Pageof 4